← Leaderboards
Marco Fazzari
University Of Pittsburgh At Pittsburgh
$2,006,289
Attributed
$2,221,476
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $601K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,221,476 · 2
By mechanism
R01$1,791,101 · 1
R21$430,375 · 1
Top collaborators
- Roberto Di Maio1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Francisco Jose Schopfer$8,044,712
- Fernando Holguin$10,342,142
- Eric Eugene Kelley$2,318,020
- Adam Carl Straub$12,143,477
- Soma Jobbagy$195,264
Others in their field
Other Emerging Leaders on “Response”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$195,683,539
- Kimberly Smith · Ppd Development Lp$115,671,664
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
Research focus
ResponseGene ExpressionInflammatoryPharmacologyIn VitroIncidenceDrug KineticsInflammationInsightNovel Drug ClassSignal TransductionMediatingInflammatory ResponseAntioxidantsCell Adhesion MoleculesCytokineBiochemicalBindingAnionsClinical DataCause Of DeathAttenuatedClinical ResearchConjugated Linoleic Acids
Grant awards (4)
Nitro-nitrate fatty acid derivatives as novel cGMP-dependent and cGMP-independent signaling mediators$601,041
R01 · FY2025 · HL · contact PI
Nitro-nitrate fatty acid derivatives as novel cGMP-dependent and cGMP-independent signaling mediators$589,019
R01 · FY2024 · HL · contact PI
Nitro-nitrate fatty acid derivatives as novel cGMP-dependent and cGMP-independent signaling mediators$601,041
R01 · FY2023 · HL · contact PI
Protective actions of the anti-inflammatory drug candidate 10-nitro-oleic acid in Parkinsonâs disease$430,375
R21 · FY2019 · NS · contact PI